Vanessa Biotech

Vanessa Biotech’s flagship product, Shylicineﾙ, is the first-ever drug developed to treat the rare and lethal microvillus inclusion disease.

Year Established: 2014 Stock Ticker: Exchange:

Locations

  • Vanessa Biotech

     Farmington CT

    Vanessa Biotech’s flagship product, Shylicineﾙ, is the first-ever drug developed to treat the rare and lethal microvillus inclusion disease.

  • Vanessa Biotech

     Hamden CT

    Vanessa Biotech’s flagship product, Shylicineﾙ, is the first-ever drug developed to treat the rare and lethal microvillus inclusion disease.